Novo Nordisk A/S (NOVC.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.06T |
| Enterprise Value | 3.07T |
| P/E Ratio | 11.12 |
| PEG Ratio | 0.66 |
| Price/Sales Ratio | 4.13 |
| Price/Book Ratio | 6.67 |
| Enterprise/Revenue | 4.52 |
| Enterprise/EBITDA | 8.32 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | 0.37 |
| Operating Margin | 0.45 |
AD
Management Effectiveness
| Return On Assets | 0.22 |
| Return On Equity | 0.66 |
Income Statement
| Revenue | 232.26B |
| Revenue/Share | 73.79 |
| Gross Profit | 196.5B |
| EBITDA | 114.63B |
| Net Income | 83.68B |
| Diluted EPS | 18.62 |
Balance Sheet
| Total Cash | 74.88B |
| Total Cash/Share | 4.87 |
| Total Debt | 56.97B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 0.79 |
| Book Value Per Share | 45.71 |
Price History
| 52-Week Change | 69.64 |
| 52-Week High | 185.12 |
| 52-Week Low | 51.65 |
| Moving Average 50 Days | 85.46 |
| Moving Average 200 Days | 74.38 |
Statistics
| Average Volume | 51,037 |
| Shares Outstanding | 4.45B |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 11.7 |
| Trailing Annual Dividend Yield | 3.84 |
| Payout Ratio | 0.42 |
| Last Split Factor | 2:1 |
| Last Split Date | September 13, 2023 |
AD
